Brief: Resonance Health Says United States Food & Drug Administration Grants 510(K) Clearance For Liversmart
30/12/2021 24:11
Dec 30 (Reuters) - Resonance Health:
* UNITED STATES FOOD & DRUG ADMINISTRATION GRANTS 510(K)
CLEARANCE
FOR LIVERSMART
* FDA CLEARANCE ALLOWS LIVERSMART, TO BE COMMERCIALLY
MARKETED AND
SOLD IN UNITED STATES OF AMERICA
Source text for Eikon: ID:nASX7stGdx
Further company coverage: RHT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Resonance Health
See all newsAustralia's Resonance Health jumps on FY26 forecast hike
Brief: Resonance Health Expects FY26 Underlying EBITDA A$2.6 Mln
Brief: Resonance Health Says Martin Blake Retires As Chair
Brief: Resonance Health Contracted For Clinical Drug Trial Worth A$13.775 Mln
Brief: Resonance Seeks Trading Halt Pending Announcement On Execution Of Contract For Services For Clinical Trial By Pharma Co